US Bancorp DE Sells 3,963 Shares of Integer Holdings Co. (NYSE:ITGR)

US Bancorp DE reduced its position in shares of Integer Holdings Co. (NYSE:ITGR) by 25.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 11,549 shares of the medical equipment provider’s stock after selling 3,963 shares during the period. US Bancorp DE’s holdings in Integer were worth $1,530,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the company. Loomis Sayles & Co. L P boosted its holdings in Integer by 3.0% in the 3rd quarter. Loomis Sayles & Co. L P now owns 538,027 shares of the medical equipment provider’s stock valued at $69,943,000 after purchasing an additional 15,446 shares during the period. Jane Street Group LLC boosted its holdings in Integer by 23.3% in the 3rd quarter. Jane Street Group LLC now owns 151,397 shares of the medical equipment provider’s stock valued at $19,682,000 after purchasing an additional 28,572 shares during the period. Verition Fund Management LLC boosted its holdings in Integer by 17.4% in the 3rd quarter. Verition Fund Management LLC now owns 3,470 shares of the medical equipment provider’s stock valued at $451,000 after purchasing an additional 515 shares during the period. Versant Capital Management Inc boosted its holdings in Integer by 98.4% in the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock valued at $49,000 after purchasing an additional 183 shares during the period. Finally, KBC Group NV boosted its holdings in Integer by 83.3% in the 4th quarter. KBC Group NV now owns 1,598 shares of the medical equipment provider’s stock valued at $212,000 after purchasing an additional 726 shares during the period. 99.29% of the stock is owned by institutional investors.

Integer Trading Down 0.3 %

Shares of Integer stock opened at $121.63 on Friday. The stock has a market capitalization of $4.09 billion, a P/E ratio of 36.20, a price-to-earnings-growth ratio of 1.72 and a beta of 1.24. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62. The company has a 50-day simple moving average of $135.47 and a 200 day simple moving average of $132.94. Integer Holdings Co. has a 12-month low of $107.11 and a 12-month high of $146.36.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share for the quarter, missing the consensus estimate of $1.46 by ($0.03). The company had revenue of $449.50 million during the quarter, compared to analyst estimates of $446.28 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. Research analysts expect that Integer Holdings Co. will post 6.01 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on ITGR shares. KeyCorp increased their price target on shares of Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Oppenheimer cut shares of Integer from an “outperform” rating to a “market perform” rating in a research note on Friday, February 21st. Benchmark increased their price objective on shares of Integer from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Friday, February 21st. Citigroup increased their price objective on shares of Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a research note on Wednesday, December 11th. Finally, Truist Financial increased their price objective on shares of Integer from $147.00 to $163.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. Two equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $147.67.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.